Activist 13D/13G Filings - Equillium Inc. (EQ)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-14
9:50 pm
Purchase
13GEquillium Inc.
EQ
Decheng Capital Management IV (Cayman) LLC5,733,021
15.600%
5,733,021increase
(New Position)
View
2024-01-19
06:03 am
Purchase
13GEquillium Inc.
EQ
TAKEDA PHARMACEUTICAL CO LTD
TAK
1,842,977
5.200%
1,842,977increase
(New Position)
View
2023-03-03
09:27 am
Sale
13GEquillium Inc.
EQ
VICTORY CAPITAL MANAGEMENT INC1,352,210
3.930%
-2,840,444decrease
(-67.75%)
View
2023-01-31
09:41 am
Purchase
13GEquillium Inc.
EQ
VICTORY CAPITAL MANAGEMENT INC4,192,654
12.200%
66,987increase
(+1.62%)
View
2022-02-14
11:57 am
Purchase
13GEquillium Inc.
EQ
Decheng Capital Management III (Cayman) LLC4,447,308
15.130%
4,447,308increase
(New Position)
View
2022-02-01
12:39 pm
Purchase
13GEquillium Inc.
EQ
VICTORY CAPITAL MANAGEMENT INC4,125,667
14.040%
1,327,535increase
(+47.44%)
View
2021-02-16
5:21 pm
Purchase
13DEquillium Inc.
EQ
Decheng Capital Global Life Sciences Fund IV L.P.5,733,021
19.700%
5,733,021increase
(New Position)
View
2021-02-03
09:34 am
Purchase
13GEquillium Inc.
EQ
VICTORY CAPITAL MANAGEMENT INC2,798,132
11.320%
564,408increase
(+25.27%)
View
2020-02-14
4:05 pm
Sale
13GEquillium Inc.
EQ
PFM Health Sciences LP0
0.000%
-1,361,866decrease
(Position Closed)
View
2020-01-29
12:12 pm
Purchase
13GEquillium Inc.
EQ
VICTORY CAPITAL MANAGEMENT INC2,233,724
12.860%
285,431increase
(+14.65%)
View